Avenue Therapeutics Stock Trading Halted Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Avenue Therapeutics (ATXI) Stock Trading Halted Today Ahead of FDA Advisory Committee Meeting
February 15, 2022 7:06 AM ESTAvenue Therapeutics, Inc. (NASDAQ: ATXI) (Avenue), a company focused on the development of intravenous (IV) tramadol for the U.S. market, today announced that NASDAQ has halted trading of the Companys common stock.
The U.S. Food and Drug Administration (FDA)... More



